Citadel Advisors LLC Purchases 82,921 Shares of Chemed Co. (NYSE:CHE)

Citadel Advisors LLC boosted its position in Chemed Co. (NYSE:CHE) by 542.3% in the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 98,213 shares of the company’s stock after purchasing an additional 82,921 shares during the period. Citadel Advisors LLC’s holdings in Chemed were worth $35,439,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other hedge funds and other institutional investors have also recently made changes to their positions in CHE. Municipal Employees Retirement System of Michigan raised its stake in shares of Chemed by 1.0% during the second quarter. Municipal Employees Retirement System of Michigan now owns 2,950 shares of the company’s stock valued at $1,064,000 after acquiring an additional 30 shares in the last quarter. Advisory Services Network LLC increased its holdings in Chemed by 117.9% during the second quarter. Advisory Services Network LLC now owns 85 shares of the company’s stock valued at $30,000 after buying an additional 46 shares during the period. Bbva USA Bancshares Inc. increased its holdings in Chemed by 2.4% during the second quarter. Bbva USA Bancshares Inc. now owns 2,579 shares of the company’s stock valued at $931,000 after buying an additional 61 shares during the period. Advisor Group Inc. increased its holdings in Chemed by 2.8% during the second quarter. Advisor Group Inc. now owns 2,305 shares of the company’s stock valued at $833,000 after buying an additional 63 shares during the period. Finally, Krane Funds Advisors LLC purchased a new position in Chemed in the second quarter worth $26,000. 87.12% of the stock is owned by institutional investors and hedge funds.

Several research firms have issued reports on CHE. Bank of America lifted their price target on shares of Chemed from $470.00 to $500.00 and gave the stock a “buy” rating in a report on Friday, September 6th. ValuEngine raised shares of Chemed from a “hold” rating to a “buy” rating in a report on Friday, June 7th. Royal Bank of Canada lifted their price target on shares of Chemed to $405.00 and gave the stock a “sector perform” rating in a report on Monday, July 29th. Finally, Oppenheimer lifted their price target on shares of Chemed from $400.00 to $430.00 and gave the stock an “outperform” rating in a report on Thursday, August 1st. One equities research analyst has rated the stock with a sell rating, one has assigned a hold rating and three have given a buy rating to the company’s stock. Chemed has a consensus rating of “Hold” and a consensus target price of $411.25.

In other Chemed news, Director George J. Walsh III bought 500 shares of the firm’s stock in a transaction that occurred on Wednesday, August 7th. The stock was bought at an average cost of $412.86 per share, for a total transaction of $206,430.00. Following the completion of the transaction, the director now directly owns 4,520 shares of the company’s stock, valued at approximately $1,866,127.20. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, insider David Patrick Williams sold 17,979 shares of the business’s stock in a transaction on Monday, August 12th. The shares were sold at an average price of $430.80, for a total transaction of $7,745,353.20. Following the transaction, the insider now owns 34,850 shares of the company’s stock, valued at $15,013,380. The disclosure for this sale can be found here. Insiders have sold 46,812 shares of company stock valued at $20,005,507 over the last quarter. Insiders own 3.96% of the company’s stock.

NYSE CHE traded up $1.06 on Friday, hitting $426.32. The stock had a trading volume of 96,598 shares, compared to its average volume of 111,213. The business’s fifty day moving average price is $425.92 and its 200 day moving average price is $362.31. The company has a debt-to-equity ratio of 0.25, a current ratio of 0.81 and a quick ratio of 0.78. Chemed Co. has a 52-week low of $260.03 and a 52-week high of $441.79. The stock has a market cap of $6.74 billion, a price-to-earnings ratio of 35.74, a price-to-earnings-growth ratio of 2.88 and a beta of 1.13.

Chemed (NYSE:CHE) last posted its quarterly earnings data on Thursday, July 25th. The company reported $3.36 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $3.09 by $0.27. Chemed had a net margin of 10.94% and a return on equity of 35.63%. The business had revenue of $473.60 million during the quarter, compared to the consensus estimate of $471.72 million. During the same period in the previous year, the firm posted $2.81 earnings per share. The business’s revenue for the quarter was up 7.2% compared to the same quarter last year. As a group, sell-side analysts anticipate that Chemed Co. will post 13.54 EPS for the current year.

The business also recently disclosed a quarterly dividend, which was paid on Tuesday, September 3rd. Stockholders of record on Monday, August 12th were paid a dividend of $0.32 per share. This is an increase from Chemed’s previous quarterly dividend of $0.30. This represents a $1.28 annualized dividend and a dividend yield of 0.30%. The ex-dividend date of this dividend was Friday, August 9th. Chemed’s payout ratio is presently 10.73%.

Chemed Company Profile

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers in the United States. It operates through two segments, VITAS and Roto-Rooter. The company also offers plumbing, drain cleaning, water restoration, and other related services to residential and commercial customers through company-owned and independent contractors, and franchised locations.

Read More: Stocks Increasing Dividends

Want to see what other hedge funds are holding CHE? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Chemed Co. (NYSE:CHE).

Institutional Ownership by Quarter for Chemed (NYSE:CHE)

Receive News & Ratings for Chemed Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Chemed and related companies with MarketBeat.com's FREE daily email newsletter.



Comments


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on reddit